The stability of cefoselis sulfate in aqueous solutions in accordance with the ICH guidelines for stability testing

Autor

  • Przemysław Zalewski Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland Autor
  • Judyta Cielecka-Piontek Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland Autor
  • Anna Jelińska Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland Autor
  • Paulina Marczak Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland Autor

DOI:

https://doi.org/10.12923/j.2084-980X/25.3/a.19

Słowa kluczowe:

cefoselis sulfate, stability in aqueous solutions, ICH Guidelines, HPLC

Abstrakt

The stability of cefoselis sulfate in accordance with the ICH Guidelines for the Stability Testing for Medicinal Substances and Pharmaceutical Products was investigated. The study was conducted at different pH, temperature, oxidative factor and with a varying exposure time. The tests of photostability were also done. Changes in cefoselis sulfate concentration were followed using the HPLC method with UV detection. Cefoselis sulfate was classified depending on the stress conditions applied and data obtained in the study as extremely labile in base pH, very labile in neutral pH, labile in acidic pH and in the presence of an oxidative factor. In the photostability test cefoselis sulfate was classified as photolabile.

Bibliografia

1. Akaho E., Nakayama H.: An innovative classification of, and a new structure-activity-relationship approach to degradation kinetics of cephalosporins: an attempt to enhance the therapeutic activity. J. Antibiot. (Tokyo), 56(4), 379, 2003.

2. Ikeda Y. et al.: Stability and Stabilization Studies of TAK-599 (Ceftaroline Fosamil), a Novel N-Phosphono Type Prodrug of Anti-methicillin Resistant Staphylococcus aureus Cephalosporin T-91825. Chem. Pharm. Bull., 56(10), 1406, 2008.

3. Jelińska A., Dobrowolski L., Oszczapowicz I.: The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions. J. Pharm. Biomed. Anal., 35(5), 1273, 2004.

4. Jelińska A. et al.: The stability of cefprozil in oral suspension cefzil. Acta Pol. Pharm., 65(2), 261, 2008.

5. Jelińska A. et al.: The stability of cefuroxime axetil in tablets. (2005) Acta Pol. Pharm., 62(3),183, 2005.

6. Jelińska A. et al.: Kinetics of cefamandole nafate degradation in solid phase. Farmaco, 58(4), 309, 2003.

7. Jelińska A., Zając M., Jakubowska M.: Kinetics of cefuroxime sodium salt decay in solid phase. React. Kinet. Catal. Lett., 73(2), 325, 2001.

8. Medenecka B. et al.: Stability of the crystalline form of cefaclor monohydrate and its pharmaceutical preparations. Acta Pol. Pharm., 66(5), 563, 2009.

9. Zając M. et al.: Evaluation of stablity of cefuroxime axetil in solid state. J. Pharm. Biomed. Anal., 32(6), 1181, 2003.

10. Zając M., Jelińska A., Zalewski P.: Stability of ceftriaxone disodium in biotrakson and tartriakson. Acta Pol. Pharm., 62(2), 89, 2005.

11. Zalewski P., Cielecka-Piontek J.: Cefoselina - nowa cefalosporyna czwartej generacji. Ann. Acad. Med. Siles. 65(3), 77, 2011.

12. Zalewski P., Cielecka-Piontek J., Jelińska A.: Development and validation of the stability-indicating LC-UV method for the determination of cefoselis sulfate. Cent. Eur. J. Chem., 10(1), 121, 2012.

13. Singh S., Bakshi M.: Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs. Pharmaceutical Technology On-Line, APRIL, 1, 2000.

Opublikowane

2012-07-01

Jak cytować

Zalewski, P., Cielecka-Piontek, J., Jelińska, A., & Marczak, P. (2012). The stability of cefoselis sulfate in aqueous solutions in accordance with the ICH guidelines for stability testing. Current Issues in Pharmacy and Medical Sciences, 25(3), 306-309. https://doi.org/10.12923/j.2084-980X/25.3/a.19